Novo Pakistan works towards long-term solutions to address diabetes care needs and support insulin access
Novo Pakistan is stepping up to support people living with diabetes amid concerns about access to insulin.
The company is working closely with its partners to play its part in supporting continuity of treatment, recognising how much dependable access to insulin means to people living with diabetes and their families.
Pakistan has an estimated 33 million people living with diabetes and more than one million relying on insulin. Novo Pakistan understands the challenge and strives to address the need for practical, long-term solutions to confront the diabetes burden in the country.
Mehtaz Sultan Khan, General Manager, Novo Pakistan, said:
Diabetes care has been at the heart of Novo for more than 100 years and delivering on that commitment remains our priority today. For people who depend on insulin, reliable access to treatment is essential. We recognise the concerns being raised and are stepping up to play our part in supporting patients in Pakistan.
As Pakistan continues to confront the growing burden of diabetes, Novo Pakistan remains committed to working alongside healthcare professionals, policymakers and patient communities to improve care.
People concerned about their prescribed insulin should speak to a healthcare professional about appropriate next steps. They can also access educational resources, guidance and connections to healthcare professionals through NovoCare.
For information and support, visit NovoCare.pk or call 021-1111-46686.
About Novo Nordisk
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. The brands purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes.
They do so by pioneering scientific breakthroughs, expanding access to their medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries.
For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.
